Composition, form of production and packaging
The gel for topical application is clear, colorless or almost colorless.
chlorhexidine dihydrochloride 50 mg
lidocaine hydrochloride 2 g
Excipients: gietelloza (hydroxyethylcellulose) - 1.5 g, glycerol - 20 g, water d / and - up to 100 g.
12.5 g - disposable polypropylene corrugated syringes (1) with elongated and breakable tip - blisters (1) - cardboard packs.
12.5 g - disposable polypropylene corrugated syringes (1) with elongated and breakable tip - blisters (5) - cardboard packs.
12.5 g - disposable polypropylene corrugated syringes (1) with elongated and breakable tip - blisters (25) - cardboard packs.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2016.
Combination drug for topical application. Has antiseptic and local anesthetic effect.
Chlorhexidine is an antimicrobial drug that acts on gram-positive and gram-negative microorganisms, yeast, dermatophytes. Effective against Gram-positive and Gram-negative bacteria - Treponema spp., Neisseria gonorrhoeae, Trichomonas spp., Chlamydia spp., Ureaplasma spp. Keeps activity (although somewhat reduced) in the presence of blood, pus, various secrets and organic substances.
Lidocaine is a local anesthetic.
Antimicrobial action and adequate anesthesia develop 5-10 min after application of the drug.
The water-soluble clear gel provides a clear optical view and has a lubricating effect for various endoscopic procedures.
- infection prevention, anesthesia in operative and diagnostic endoscopic interventions in children and adults in urology, gynecology, proctology, all forms of endoscopy, replacement of fistula catheters, intubation;
- is used in complex therapy for the relief of inflammation symptoms (accompanied by pain syndrome) of the mucous membrane of the urethra, vagina, cervical canal and rectum.
For slow instillation before the introduction of instruments (by a doctor or specially trained personnel) it is necessary:
- Open the blister by removing the paper from the transparent body (if possible, only until the waistband);
- break the tip without significant effort (if possible still in the package). It should be ensured that the tip is completely removed, in order to avoid damage to the mucosa. To facilitate administration, it is recommended that
pre-squeeze a drop of gel;
-Instillation by light pressure on the corrugated syringe. After emptying the syringe, it must be kept in a compressed state until seizure.
-Introduction of instruments is recommended to be carried out 5-10 minutes after instillation gel.
Allergic reactions: with increased sensitivity, allergic dermatitis, skin rash, angioedema can occur.
Local reactions: burning in the place of application.
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
With caution should be used in the I trimester of pregnancy.
In the case of lactation, refrain from breastfeeding for 12 hours after use.
The drug is sterile and is intended for single administration.
Regional and local anesthesia should be carried out by experienced specialists in an appropriately equipped room with availability of ready-to-use equipment and preparations necessary for cardiac monitoring and resuscitation. Personnel performing anesthesia should be qualified and trained in the technique of performing anesthesia, should be familiar with the diagnosis and treatment of systemic toxic reactions, adverse events and other complications.
Symptoms (with systemic action of lidocaine in cases of severe damage to the urethra): bradycardia, convulsions, collapse.
Treatment: with bradycardia - beta-adrenostimulants, with convulsions - barbiturates or short-acting muscle relaxants, in case of collapse - epinephrine or dopamine is administered IV.
Avoid joint use with iodine preparations.
MAO inhibitors enhance the local anesthetic effect of lidocaine.
Incompatible with soap, as well as detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethyl cellulose).
Compatible with drugs containing a cationic group (benzalkonium chloride).
TERMS OF RELEASE FROM PHARMACY
TERMS AND CONDITIONS OF STORAGE
The drug should be stored in a dark place at a temperature of + 15 В° to + 25 В° C. Shelf life - 5 years. Do not use after the expiry date printed on the package.
Keep out of the reach of children.